Sonar Reasoning Pro

Analyze the feasibility of fusion energy becoming a mainstream power source by 2040, including technical, economic, and regulatory hurdles.<think>Step 1: Current fusion progress - ITER delayed to 2035, private firms like Commonwealth Fusion targeting 2028 demos. Step 2: Scalability challenges - net energy gain rare, materials degrade under neutron flux. Step 3: Economics - $20-30B per plant, LCOE 2x solar today. Step 4: Regulations - NRC approvals slow. Conclusion: Unlikely by 2040, possible post-2050.</think>{"feasibility": "low", "timeline": "post-2040", "key_barriers": ["tech_maturity", "cost", "regulation"]}

Compare investment risks of quantum computing stocks vs. biotech ETFs, factoring market trends and volatility.<think>Step 1: Quantum stocks (e.g., IONQ) - high beta 2.5, 80% drawdowns, nascent tech. Step 2: Biotech ETFs (e.g., XBI) - beta 1.4, regulatory approvals drive 20-50% swings. Step 3: Trends - quantum funding up 30% YoY, biotech M&A steady. Step 4: Risk - quantum higher volatility, longer horizon. Recommendation: Diversify with 70% biotech.</think>{"quantum_risk": "high_volatility_long_term", "biotech_risk": "regulatory_event_driven", "allocation": "70% biotech"}